Digital BIO-Europe Spring Digital: Big data and AI panel discussion The combination of big data and artificial intelligence/machine learning is a powerful one and nowhere more so than in healthcare.
Views & Analysis Are microtaggants the key to making medicines smarter? Pharmaceutical companies are accountable for ensuring that their medicine is safe when it comes into the hands of patients.
Digital Now what? The future of clinical trials after the pandemic Sheila Rocchio highlights four key areas life sciences must improve on as an industry to drive real change in how clinical trials are conducted.
Views & Analysis AI, big data and real world evidence – the challenges and op... Real-world evidence (RWE) is emerging as an important area of research to reveal, in real time, new insights and innovations in medicine.
Views & Analysis The Online Safety Bill: a step towards digitally safe mental... The UK government’s Online Safety Bill has been
Sales & Marketing Key insights for a successful first-time product launch Pre-commercial & Emerging pharma companies may not think they have the resources to match the launch strategies of big pharma.
Oncology LSX2026: Addressing adult eye cancer, with Roi Raz Roi Raz, CEO of ReBio Pharma, discusses injectable, bioresorbable sustained release delivery for ophthalmic therapeutics at LSX 2026.
Sales & Marketing Sponsored Using AI-driven synthetic personas to take your insights fur... As AI continues to reshape the healthcare landscape, pharma teams are beginning to leverage synthetic personas.